The Effects of a High Fat and Low Carbohydrate Diet on Clinical Status in Patients With Heart Failure

NCT02150798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2019-02-07

No results posted yet for this study

Summary

The aim of the present study was to evaluate the effects of a high fat, low carbohydrate (CHO) diet on clinical status during 60 days of follow-up in patients with stable heart failure (HF).

In a randomized controlled clinical trial 44 ambulatory patients with HF were included, assigned to an intervention (40% CHO, 40% fat and 20% protein; n=22) or control groups (50% CHO, 30% fat, 20% protein; n=20). Both groups received recommended pharmacological management. At baseline and at 2 months of follow-up, the variables evaluated were: body composition, handgrip strength, oxygen saturation, dietary intake, clinical data, lipid profile, plasma glucose and exercise tolerance

Conditions

Interventions

OTHER

High fat and low carbohydrate diet

high fat and low carbohydrate diet. At baseline and at 2 month of following, the variables that were evaluated,

OTHER

Control diet

Control diet. At baseline and at 2 month of following, the variables that were evaluated,

Sponsors & Collaborators

  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

    lead OTHER

Principal Investigators

  • Dulce G Gonzalez, M.Sc. · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Lilia Castillo, M.Sc. · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Arturo Orea, MD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Gabriela Olvera, B.Sc · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Karla Balderas, B.Sc. · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Cira Santillán, M.Sc. · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Wendy Rodríguez, M.Sc. · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-12-31
Completion
2013-03-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02150798 on ClinicalTrials.gov